Shandong Weigao repurchases shares on exchange

On July 4, 2025, Shandong Weigao Group Medical Polymer Company Limited (HKEX:1066) repurchased 80,000 of its own shares on the Hong Kong Stock Exchange. The shares were bought at prices ranging from HKD 6.08 to HKD 6.10, with the total consideration paid being HKD 487,000. This repurchase represents approximately 0.0018% of the existing issued shares before the event. Following the transaction, the company's number of issued shares (excluding treasury shares) decreased to 4,514,119,924 and treasury shares increased to 8,212,400. The repurchase was within the mandate approved on May 27, 2025, authorizing the company to repurchase up to 451,560,392 shares. The company confirmed that the repurchase adhered to exchange rules and that there were no material changes to the explanatory statement.